To include your compound in the COVID-19 Resource Center, submit it here.

CHMP recommends Gilead’s sofosbuvir/velpatasvir/voxilaprevir combo for HCV infection

EMA’s CHMP recommended approval of an MAA from Gilead Sciences Inc.

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE